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ABSTRACT
Objective: To investigate the frequency of 22q11 deletion syndrome (22q11DS) in pa-
tients with complex congenital heart disease. Methods: A prospective and consecutive 
cohort of patients with complex heart defects was evaluated in their first hospitalization 
at a cardiac intensive care unit of a pediatric hospital. For each patient, an assessment 
form was completed with demographic information and clinical evaluation. High reso-
lution karyotyping and fluorescence in situ hybridization (FISH) to detect the presence 
of 22q11 microdeletion, were performed. Heart defects were classified by a cardiologist. 
Results: The sample cohort consisted of 66 patients. Karyotypic anomalies were observed 
in 5 patients (7.6%); however, none of them had 22q11 deletion. Evaluation by FISH was 
successfully done in 65 patients, identifying 22q11 microdeletion in two patients (3.1%). 
Out of the 66 patients with complex defects, 52 were carriers of conotruncal malforma-
tions and in 51 patients, analysis for 22q11 microdeletion by FISH was performed. The 
two patients with 22q11 microdeletion belonged to this group, representing a frequency 
of 3.9%. They had tetralogy of Fallot. Conclusion: 22q11DS is a frequent abnormality 
among patients with complex and conotruncal heart defects. Variations of the 22q11DS 
frequency among studies seem to be mainly associated with criteria used for patient 
selection and specific characteristics of the population analyzed.
Keywords: DiGeorge syndrome; in situ hybridization; fluorescence; heart defects; con-
genital, chromosomes; human; pair 22.
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INTRODUCTION
Congenital cardiac malformations represent a hetero-
geneous group of diseases with variable hemodynamic 
consequences and, therefore, with difierent follow-up and 
intervention needs. Among these malformations, we high-
light the complex heart defects, particularly for its sever-
ity. Also within this subgroup are the conotruncal heart 
defects characterized by changes in the heart outflow tract. 
These correspond to approximately 50% of congenital car-
diopathies seen in newborns1, representing an important 
association with genetic disorders, especially 22q11 dele-
tion syndromes (22q11DS, OMIM #188400/#192430)2, 
also known as velocardiofacial syndrome or DiGeorge 
syndrome3,4.
This syndrome is characterized clinically by a high 
phenotypic variability, without pathognomonic findings, 
hindering its diagnosis. It is due to a deletion in the region 
11 of the long arm of chromosome 22 (i.e., 22q11), being 
an autosomal dominant disorder afiecting families, i.e., 
an afiected individual has a 50% chance of transmitting 
it to his/her children. As for its diagnosis, high-resolution 
karyotyping has limitations and is able to identify less than 
15% of afiected patients. Fluorescence in situ hybridization 
(FISH), which can detect over 90% of the cases, is consid-
ered the gold standard5,6.
Therefore, due to the almost non-existence of related 
studies among us and the variability of the indices ob-
served in literature, the objective of the present study was 
to determine the frequency of 22q11DS among patients 
with complex heart defects.
METHODS
This study was performed on a prospective and consecu-
tive cohort of patients in their first hospitalization due to 
congenital cardiac malformation in the Cardiological In-
tensive Care Unit (CICU) of Hospital da Criança Santo 
Antonio (HCSA)/Complexo Hospitalar Hospital Santa 
Casa de Porto Alegre (CHSCPA) during one year. This co-
hort was part of the study by Rosa et al. For each patient, 
an assessment form with clinical data, such as gender, age, 
race, precedence, reason for admission, and cardiological 
diagnosis was completed. Description of cardiac malfor-
mations, as well as their classification into complex and 
conotruncal defects was performed by a cardiologist par-
ticipating in the study, always taking into consideration 
the results of echocardiogram, cardiac catheterization, 
and description of the cardiac surgery. Patients also un-
derwent high resolution band karyotyping (fi 550 bands) 
and fluorescence in situ hybridization to detect 22q11 mi-
crodeletion using the commercially available DNA probe 
DiGeorge/VCFS Region Probe (TUPLE 1), followed by a 
standard codenaturation protocol.
The SPSS (version 12.0) and PEPI (version 4.0) sofi-
wares were used for data processing and analysis. Fischer’s 
exact test was used to compare the frequencies observed in 
our study and in literature. Values of p < 0.05 were consid-
ered significant. This study was approved by the Research 
Ethics Committee of UFCSPA and CHSCPA.
RESULTS
Out of 207 patients with congenital cardiopathies hospi-
talized for the first time in the CICU, and whose guard-
ians consented to their participation in the study, 66 
(31.9%) had complex malformations. Forty-three were 
males (62.5%) and 23 females (34.8%), and the major-
ity were Caucasians (77.3%). Their ages ranged from 1 
day to 10 years (51% were younger than 1 month). Most 
patients were from the country side of Rio Grande do Sul 
State (59.1%), and cardiac surgery was the main reason 
for CICU admission (74.2%). Heart defects presented 
by the patients are listed in Table 1. Tetralogy of Fal-
lot (30.3%) was the most important of these defects. As 
for karyotyping, changes were observed in five patients 
(7.6%): four with free chromosome 21 trisomy, and one 
with free chromosome 18 trisomy. No case of 22q11 de-
letion was identified by this examination. Analysis us-
ing FISH technique was successfully performed in 65 
patients, identifying 22q11 microdeletion in two cases 
(3.1%) (two patients with tetralogy of Fallot). Out of 66 
patients with complex cardiac defects, 52 patients had 
conotruncal defects, and 51 of them underwent inves-
tigation for 22q11 microdeletion. The two patients with 
22q11 microdeletion were in this group, representing a 
frequency of 3.9% (2/51) (Table 2).
DISCUSSION
In our literature review, we found only one study evaluat-
ing the frequency of 22q11DS among patients with com-
plex heart defects. Mehraein et al.7, evaluating a cohort 
of 40 patients, observed a deletion index of 22.5%. This 
was significantly higher than in our study (3.1%). We 
believe that this might be related to selection criteria in 
the first study, which evaluated a cohort originated from 
departments of clinical genetics and pediatric cardiology 
in Germany.
It is known that 22q11DS has an important relation-
ship with conotruncal defects3, and, in our cohort, 52 out 
of 66 (78.8%) patients with complex congenital cardiopa-
thy had this defect. They represented all individuals with 
conotruncal defect in the initial cohort of 207 patients. The 
frequency of 22q11DS in our study (3.9%) was similar to 
other indices, which are between 4% and 15%4,8-15, but dif-
ferent from others who reported indices between 17% and 
49%1,16-20 (Table 2). These difierences seem to be particu-
larly related to the age of patients, their precedence, and 
frequency of specific heart defects, such as interruption of 
the aortic arch, which, among the conotruncal malforma-
tions, is associated even more with 22q11DS.
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Congenital heart defects Total N
Normal Karyotype Abnormal karyotype and normal FISH
Normal FISH del22q11.2 Without FISH +21 +18
  TOF * 20 14 2 3 1
  TGV * 12 11 1
  LV hypoplasia 8 8
  PA + NS * 5 5
  PA + IVC * 5 5
  RVDO * 4 4
  TA 4 4
  AT * 3 3
  LVDO * 2 2
  TAPVR 2 2
  AVSD (+ TOF) * 1 1
Total 66 58 2 1 4 1
% + 100 88 3 1,5 6 1,5
PA, pulmonary atresia; TA, tricuspid atresia; IVC, interventricular communication; AVSD, atrioventricular septal defect; LVDO, left ventricular 
double outlet; RVDO, right ventricular double outlet; TAPVR, total anomalous pulmonary venous return; NS, normal septum; TA, truncus 
arteriosus; TGV, transposition of the great vessels; TOF, tetralogy of Fallot; LV, left ventricle; +21, free trisomy of chromosome 21; +18, free 
trisomy of chromosome 18; *Conotruncal defects in the cohort; + Calculated in 66 patients. 
Table 1 – Congenital heart defects observed, classified according to the results of karyotypic analysis and FISH technique
Iserin et al.1 described a higher index of 22q11DS (48%) 
when evaluating newborns seen in a pediatric cardiology 
service in France, who presented with conotruncal defects 
more commonly associated with this syndrome (Table 2). 
It is known that these are severe defects and, depending on 
the age of evaluation and place of birth, individuals might 
not be alive to be evaluated, as suggested by Rosa et al.3. 
This situation is even worse in places where prenatal diag-
nosis of congenital cardiopathies is inadequate and there 
is not an appropriate infrastructure for adequate care and 
treatment of those patients, as in our case3. On the other 
hand, Voigt et al.11, who found a frequency of SD22q11 
quite similar to our work (4%), evaluated a group of pa-
tients who underwent cardiac catheterization in a cardi-








Iserin et al.1 NB 104 95 (44) 9 (6) 50 (48) 0.0000
Derbent et al.20 1 m - 9 y 30 ND (5) ND (4) 9 (30) 0.0016
Goldmuntz et al.16 ND 17 17 (5) - 5 (29) 0.0088
Goldmuntz et al.18 ND 251 179 (42) 72 (3) 45 (18) 0.0100
Webber et al.17 1d - 4m 46 41 (6) 5 (2) 8 (17) 0.0434
Worthington et al.19 ND 90 81 (13) 9 (2) 15 (17) 0.0306
Khositseth et al.14 ND 61 49 (8) 12 (1) 9 (15) 0.0639
Devriendt et al.8 ND 140 ND ND 18 (13) 0.1071
Lewin et al.9 ND 73 53 (7) 20 7 (10) 0.3054
Anaclerio et al.12 1 d - 5 y 329 ND (27) - 27 (8) 0.3999
Takahashi et al.10 1 m - 16 y 64 35 (4) 29 (1) 5 (8) 0.4604
Ziolkowska et al.4 0 - 20 y 214 160 (ND) 54 (ND) 15 (7) 0.5401
Beauchesne et al.3 18 y - 70 y 103 103 (6) - 6 (6) 1.0000
Lammer et al.15 ND 485 296 (30) 189 30 (6) 0.5320
Voigt et al.11 4 d - 58 y 100 42 (4) 58 4 (4) 1.0000
Present study 1 d - 10 y 51 28(2) 23 2 (4) -
N, number of patients; NB, newborn; d, days; m, months; y, years; ND, not described; *Numbers in parenthesis correspond to patients with 
22q11DS and respective conotruncal defect; +, Conotruncal defects more commonly associated with 22q11DS: AAI (aortic arch interruption); 
TA (truncus arteriosus); TOF (tetralogy of Fallot); IVC/PA (interventricular communication with pulmonary atresia).
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ology center in Germany. Note that these patients were 
characterized by more advanced age, ranging from 4 days 
to 58 years (mean 6.1 years), a high frequency of transpo-
sition of great vessels (a defect with little association with 
22q11DS), and absence of aortic arch interruption, similar 
to what was observed in our cohort (Table 2).
Most of these studies do not describe patients with dif-
ferent chromosomal abnormalities other than 22q11DS. 
In our study, patients with Down’s syndrome and Edwards’ 
syndrome were identified. In this case, we do not know 
whether it is related to type of patient selection or even 
the population characteristics, since in many cases, those 
studies were performed in countries where, unlike Brazil, 
gestational interruption in cases of fetus with chromosom-
al anomalies is allowed. Thus, these aspects could interfere 
with the frequencies observed among individuals in the 
postnatal period. On the other hand, in other studies, such 
as Worthington et al.19, patients with chromosomal abnor-
malities, or even those with an identifiable non-22q11DS 
syndrome, were excluded (Table 2).
CONCLUSION
In conclusion, 22q11DS is a common abnormality among 
patients with complex congenital heart and conotruncal 
defects. Variations between studies seem to be associated 
mainly with the selection process and characteristics of the 
population. Identification of these patients is essential for 
their adequate management and genetic counseling.
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